HBOT News & Research
Hyperbaric Oxygen Therapy (HBOT) is increasingly appearing in the news and new research as a treatment for a variety of conditions involving inflammation. Use the search or select an article below to keep up to date on the most recent HBOT News.
Recent Hyperbaric Oxygen Therapy (HBOT) News
Necrotizing fasciitis. A perioperative case study.
Abstract: NF involves rapidly spreading inflammation with necrosis of superficial fascia, fat, and possibly muscle and epidermis. Severe systemic toxicity can be associated with NF and mortality rates can reach 74% with this so called flesh eating...
[131I meta-iodobenzylguanidine in combination with hyperbaric oxygen therapy in the treatment of prognostically high-risk forms of neuroblastoma].
Abstract: Despite of improving diagnostics, development of new drugs and treatment strategies, patients with biologically unfavourable, advanced or relapsed neuroblastoma remain practically incurable. Treatment related toxicity, requirement for...
Radiation Therapy Oncology Group clinical trials for carcinoma of the cervix.
Abstract: Grigsby PW. Radiation Therapy Oncology Group clinical trials for carcinoma of the cervix. The purpose of this paper is to review the primary data of the clinical trials performed by the Radiation Therapy Oncology Group (RTOG) for patients...
Hyperbaric oxygen therapy for late sequelae in women receiving radiation after breast-conserving surgery.
Abstract: Persisting symptomatology after breast-conserving surgery and radiation is frequently reported. In most cases, symptoms in the breast resolve without further treatment. In some instances, however, pain, erythema, and edema can persist for...
Rhino-orbitocerebral mucormycosis attributable to Apophysomyces elegans in an immunocompetent individual: case report and review of the literature.
Abstract: Garcia-Covarrubias, Bartlett, Barratt, Wassermann, , , , , (2001). Rhino-orbitocerebral mucormycosis attributable to Apophysomyces elegans in an immunocompetent individual: case report and review of the literature. The Journal of trauma,...
Double-blind randomized phase II study of hyperbaric oxygen in patients with radiation-induced brachial plexopathy.
Abstract: Radiation-induced brachial plexopathy (RIBP) is an untreatable complication of curative radiotherapy for early breast cancer, characterized by chronic neuropathic pain and limb paralysis. Hyperbaric oxygen (HBO2) therapy is known to...
Double-blind randomized phase II study of hyperbaric oxygen in patients with radiation-induced brachial plexopathy.
Abstract: Radiation-induced brachial plexopathy (RIBP) is an untreatable complication of curative radiotherapy for early breast cancer, characterized by chronic neuropathic pain and limb paralysis. Hyperbaric oxygen (HBO2) therapy is known to...
Double-blind randomized phase II study of hyperbaric oxygen in patients with radiation-induced brachial plexopathy.
Abstract: Radiation-induced brachial plexopathy (RIBP) is an untreatable complication of curative radiotherapy for early breast cancer, characterized by chronic neuropathic pain and limb paralysis. Hyperbaric oxygen (HBO2) therapy is known to...
Use of 5-FU plus hyperbaric oxygen for treating malignant tumors: evaluation of antitumor effect and measurement of 5-FU in individual organs.
Abstract: Hyperbaric oxygen (HBO) has been shown to increase tumor radiosensitivity. Several reports indicate that it also increases sensitivity to alkylating agents, but other reports suggest that it may speed angiogenesis and tumor growth. To...